LIDR Nasdaq Motor Vehicle Parts & Accessories Financials FY2019βFY2025
AEye, Inc. had $0.2M of revenue in fiscal 2025, up 15.3% on the year before. Over five years, revenue changed β31.8% a year on average.
Last close Β· Oct 23, 2026
$0.99
10.4%Hi! I read AEye, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+15.3%
Yes. Sales grew 15.3% last year.
Does it make a profit?
β14,574.2%
No. It lost money last year.
Does profit turn into cash?
β11,968.2%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· AEye, Inc. had $0.2M of revenue in fiscal 2025, up 15.3% on the year before. Over five years, revenue changed β31.8% a year on average. Its operating margin was β13,618.5%, up 4,118.2Β pts: of every 100 in sales, about β13,618 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· AEye, Inc. lost $34.0M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$27.9M in fiscal 2025, β11,968.2% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders bought $0.0M and sold $0.1M of shares on the open market.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
1 insider
Sold, 12 months
$0.1M
2 insiders
Of sales under plans
0%
$0.0M
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably AEye, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $164M | $94.2M | $36.5M | $22.3M | $86.5M |
| Debt incl. finance leases | $0.0M | $8.6M | β | β | β |
| Debt / equity | 0.0x | 0.1x | β | β | β |
| Current ratio | 13.1x | 4.7x | 4.0x | 2.2x | 10.5x |
| Quick ratio | 12.8x | 4.5x | 3.9x | 2.2x | 10.3x |
| Total assets | $186M | $133M | $54.3M | $27.1M | $90.9M |
| Total liabilities | $17.4M | $39.4M | $25.3M | $12.0M | $9.6M |
| Shareholders' equity | $169M | $94.0M | $29.0M | $15.1M | $81.3M |
| Net debt (β = net cash) | β$164M | β$85.6M | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· AEye, Inc. passes 4 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 1 | β / 5 | 4 / 9 | 3 / 9 | 1 / 8 | 3 / 8 | 4 / 8 |
| Accruals ratio | β | β53.0% | β8.8% | β16.9% | β38.8% | β21.7% | β10.5% |
| Altman Z'' | 2,504.05 | β22.83 | 11.02 | β4.52 | β26.33 | β49.05 | β2.15 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | β | $1.6M | $3.0M | $3.6M | $1.5M | $0.2M | $0.2M |
| Gross profit | β | $0.8M | β$0.6M | β$5.1M | β$13.9M | β$0.6M | β$0.3M |
| Research and development | β | $17.1M | $26.5M | $37.6M | $26.2M | $16.4M | $13.9M |
| Operating income | β$0.0M | β$26.5M | β$63.2M | β$98.8M | β$87.8M | β$35.8M | β$31.7M |
| Pretax income | β$0.0M | β$2.9M | β | β | β$87.1M | β$35.5M | β$33.9M |
| Income tax | β | $0.0M | $0.0M | $0.1M | $0.1M | β$0.0M | $0.0M |
| Net income | β$0.0M | β$26.6M | β$65.0M | β$98.7M | β$87.1M | β$35.5M | β$34.0M |
| Net income to common | β | β$2.7M | β | β | β | β | β |
| Diluted EPS | β | β$0.26 | β$0.60 | β$18.82 | β$14.95 | β | β |
| Diluted shares | β | 0.10B | 0.11B | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | |||||||
| Cash from operations | β | β$19.7M | β$55.7M | β$71.6M | β$50.7M | β$26.6M | β$27.8M |
| Capital expenditure | β | $4.0M | $1.0M | $4.2M | $2.0M | $0.5M | $0.1M |
| Free cash flow | β | β$23.7M | β$56.7M | β$75.8M | β$52.7M | β$27.1M | β$27.9M |
| Depreciation and amortization | β | $0.9M | $1.0M | $1.4M | $1.5M | $0.1M | $0.2M |
| Stock-based compensation | β | $2.0M | $10.0M | $24.0M | $18.1M | $9.0M | $5.5M |
| Balance sheet | |||||||
| Cash and short-term investments | $0.0M | $15.3M | $164M | $94.2M | $36.5M | $22.3M | $86.5M |
| Total debt | β | $34.7M | $0.0M | $8.6M | β | β | β |
| Current assets | $0.0M | $19.5M | $177M | $106M | $39.8M | $25.2M | $89.6M |
| Current liabilities | $0.0M | $37.6M | $13.6M | $22.6M | $10.0M | $11.3M | $8.6M |
| Inventory | β | $2.7M | $4.1M | $4.6M | $0.6M | $0.2M | $1.0M |
| Property and equipment, net | β | $4.9M | $5.1M | $7.7M | $0.3M | $0.6M | $0.6M |
| Total assets | $0.0M | $25.9M | $186M | $133M | $54.3M | $27.1M | $90.9M |
| Total liabilities | $0.0M | $44.1M | $17.4M | $39.4M | $25.3M | $12.0M | $9.6M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $5.7M | β$18.2M | $169M | $94.0M | $29.0M | $15.1M | $81.3M |
| Margins | |||||||
| Gross margin | β | 48.8% | β21.0% | β139.4% | β946.4% | β285.1% | β137.8% |
| Operating margin | β | β1,677.1% | β2,102.9% | β2,709.3% | β5,995.6% | β17,736.6% | β13,618.5% |
| EBITDA margin | β | β1,618.7% | β2,069.2% | β2,670.3% | β5,890.0% | β17,672.8% | β13,551.9% |
| Net margin | β | β1,681.5% | β2,162.0% | β2,706.7% | β5,951.2% | β17,554.5% | β14,574.2% |
| FCF margin | β | β1,502.5% | β1,886.4% | β2,079.8% | β3,598.1% | β13,418.8% | β11,968.2% |
| Returns | |||||||
| Return on capital | β | β1,809.8% | β1,049.5% | β933.2% | β | β | β |
| Return on capital employed | β2.2% | 226.1% | β36.6% | β89.2% | β198.2% | β226.6% | β38.5% |
| Return on equity | β0.0% | β | β86.4% | β75.1% | β141.7% | β160.6% | β70.4% |
| Return on assets | β2.0% | β204.9% | β61.3% | β61.8% | β92.9% | β87.1% | β57.5% |
| Return on tangible equity | β0.0% | β | β38.5% | β105.0% | β300.2% | β234.5% | β41.7% |
| Growth | |||||||
| Revenue growth | β | β | 90.4% | 21.3% | β59.9% | β86.2% | 15.3% |
| Share count change | β | β | 6.1% | β95.2% | 11.1% | 24.5% | 218.8% |
| Financial health | |||||||
| Debt / equity | β | β | 0.0x | 0.1x | β | β | β |
| Current ratio | 10.4x | 0.5x | 13.1x | 4.7x | 4.0x | 2.2x | 10.5x |
| Quick ratio | 10.4x | 0.4x | 12.8x | 4.5x | 3.9x | 2.2x | 10.3x |
| Capital allocation | |||||||
| Capex / revenue | β | 255.6% | 34.0% | 115.2% | 133.3% | 240.6% | 46.8% |
| Stock comp / revenue | β | 123.6% | 333.2% | 657.0% | 1,234.4% | 4,478.7% | 2,370.0% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 4.0 | 3.0 | 1.0 | 3.0 | 4.0 |
| Altman Z'' | 2,504.0 | β22.8 | 11.0 | β4.5 | β26.3 | β49.0 | β2.2 |
| Accruals ratio | β | β53.0% | β8.8% | β16.9% | β38.8% | β21.7% | β10.5% |
Source: SEC EDGAR XBRL filings (CIK 0001818644). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
